These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9506656)

  • 21. Medical therapy of patients with reflux oesophagitis poorly responsive to H2-receptor antagonist therapy.
    Klinkenberg-Knol EC; Meuwissen SG
    Digestion; 1992; 51 Suppl 1():44-8. PubMed ID: 1356868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of intragastric pH on control of peptic ulcer bleeding.
    Li Y; Sha W; Nie Y; Wu H; She Q; Dai S; Jia L; Yu W
    J Gastroenterol Hepatol; 2000 Feb; 15(2):148-54. PubMed ID: 10735538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
    Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
    Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful medical treatment of peptic pyloric stenosis: Dr Sippy revisited.
    Khandekar S; Chandler ST; Trewby PN
    J R Coll Physicians Lond; 1998; 32(4):354-7. PubMed ID: 9762631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent non-response to histamine H2-receptor antagonists in cirrhotics.
    Walker S; Krishna DR; Klotz U; Bode JC
    Gut; 1989 Aug; 30(8):1105-9. PubMed ID: 2570008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reflux esophagitis: therapeutic indications].
    Cloarec D; Bruley des Varannes S; Galmiche JP
    Rev Prat; 1988 Feb; 38(4):237-48. PubMed ID: 2895495
    [No Abstract]   [Full Text] [Related]  

  • 28. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. International Pediatric Omeprazole Study Group.
    Hassall E; Israel D; Shepherd R; Radke M; Dalväg A; Sköld B; Junghard O; Lundborg P
    J Pediatr; 2000 Dec; 137(6):800-7. PubMed ID: 11113836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Omeprazole in the therapy of acid-induced diseases].
    Simon B; Dammann HG; Müller P
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Conservative therapy of reflux esophagitis].
    Koop H
    Z Gastroenterol Verh; 1990 Apr; 25():135-7. PubMed ID: 1694350
    [No Abstract]   [Full Text] [Related]  

  • 33. [Complementary medicine. Phytotherapy in gastrointestinal ulcer].
    Praxis (Bern 1994); 2004 Apr; 93(16):682-3. PubMed ID: 15127989
    [No Abstract]   [Full Text] [Related]  

  • 34. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
    Sontag SJ
    Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maintenance therapies for reflux esophagitis.
    Yarze JC
    N Engl J Med; 1996 Feb; 334(9):600-1. PubMed ID: 8569839
    [No Abstract]   [Full Text] [Related]  

  • 36. Omeprazole for severe reflux esophagitis in children.
    De Giacomo C; Bawa P; Franceschi M; Luinetti O; Fiocca R
    J Pediatr Gastroenterol Nutr; 1997 May; 24(5):528-32. PubMed ID: 9161946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug therapy of reflux oesophagitis: an update.
    Tytgat GN
    Scand J Gastroenterol Suppl; 1989; 168():38-49. PubMed ID: 2575792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lansoprazole and omeprazole in the treatment of acid peptic disorders.
    Blum RA
    Am J Health Syst Pharm; 1996 Jun; 53(12):1401-15. PubMed ID: 8781686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of omeprazole and histamine H2-receptor antagonists in the treatment of elderly and young patients with reflux oesophagitis.
    James OF; Parry-Billings KS
    Age Ageing; 1994 Mar; 23(2):121-6. PubMed ID: 8023719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations.
    Bate CM; Keeling PW; O'Morain C; Wilkinson SP; Foster DN; Mountford RA; Temperley JM; Harvey RF; Thompson DG; Davis M
    Gut; 1990 Sep; 31(9):968-72. PubMed ID: 2210463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.